Study Results Emerge; Arena Shares Dip, Kick Up

Arena Pharmaceuticals said its weight loss drug candidate lorcaserin succeeded in a final trial that sets the stage for its upcoming FDA application, although the drug’s effectiveness appeared to trail the competition.
San Diego Business Journal